This update said what it needed to say... all very encouraging. The broadening of the current asset into other cancers and the build out of additional assets which will significantly de-risk the company and add to the addressable market as mentioned by previous posters.
I liked when Jennifer Chow was describing our “First asset” and look forward to the news of additional assets to develop. The slide with the management teams experience was interesting as well as all three worked at Celgene in global roles which again highlights the quality of the management. I feel they will continue to add to this team as they build out the team.
bit of a slow day and tough to get orders executed
I was surprised that a good chunk of one my orders went through at once
CHM Price at posting:
31.0¢ Sentiment: Buy Disclosure: Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)